Author:
Ke Yi-Yu,Singh Vivek Kumar,Coumar Mohane Selvaraj,Hsu Yung Chang,Wang Wen-Chieh,Song Jen-Shin,Chen Chun-Hwa,Lin Wen-Hsing,Wu Szu-Huei,Hsu John T. A.,Shih Chuan,Hsieh Hsing-Pang
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Jemal, A., Thomas, A., Murray, T. & Thun, M. Cancer statistics, 2002. CA: a cancer journal for clinicians 52, 23–47 (2002).
2. Burnett, A. K. Treatment of acute myeloid leukemia: are we making progress? Hematology Am. Soc. Hematol. Educ. Program. 1–6 10.1182/asheducation-2012.1.1 (2012).
3. Gilliland, D. G. & Griffin, J. D. The roles of FLT3 in hematopoiesis and leukemia. Blood 100, 1532–1542 10.1182/blood-2002-02-0492 (2002).
4. Fathi, A. T. & Chen, Y. B. Treatment of FLT3-ITD acute myeloid leukemia. Am. J. Blood Res. 1, 175–189 (2011).
5. Smith, C. C. et al. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature 485, 260–U153 10.1038/Nature11016 (2012).
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献